Ab Index-Nr. 609-027-00-8

Index-Nr.Internationale chemische BezeichnungEG-Nr.CAS-Nr.EinstufungKennzeichnungbis 30.11.2018: Spezifische Konzentrations-
grenzen,
M-Faktoren
ab 01.12.2018: Spezifische Konzentrations-
grenzen
M-Faktoren und ATE
Anmer-
kungen
Gefahrenklasse, Gefahren-
kategorie und Gefahren-
kodierung
Kodierung der Gefahrenhin-
weise
Piktogramm, Kodierung der SignalworteKodierung der Gefahrenhin-
weise
Kodierung der ergänzenden Gefahren-
merkmale
609-027-00-8dinocton;
reaction mass of isomers: methyl 2-octyl-
4,6-dinitrophenyl carbonate, methyl 4-octyl-
2,6-dinitrophenyl carbonate
63919-26-6Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
   
609-028-00-3dinex (ISO);
2-cyclohexyl-4,6-dinitrophenol
205-042-5131-89-5Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Aquatic Acute 1
Aquatic Chronic 1
H331
H311
H301
H400
H410
GHS06
GHS09
Dgr
H331
H311
H301
H410
   
609-029-00-9salts and esters of dinexAcute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Aquatic Acute 1
Aquatic Chronic 1
H331
H311
H301
H400
H410
GHS06
GHS09
Dgr
H331
H311
H301
H410
  A
609-030-00-4dinoterb (ISO);
2-tert-butyl-4,6-dinitrophenol
215-813-81420-07-1Repr. 1B
Acute Tox. 2 (*)
Acute Tox. 3 (*)
Aquatic Acute 1
Aquatic Chronic 1
H360D
(*)(*)(*)
H300
H311
H400
H410
GHS06
GHS08
GHS09
Dgr
H360D
(*)(*)(*)
H300
H311
H410
EUH044  
609-031-00-Xsalts and esters of dinoterbRepr. 1B
Acute Tox. 2 (*)
Acute Tox. 3 (*)
Aquatic Acute 1
Aquatic Chronic 1
H360D
(*)(*)(*)
H300
H311
H400
H410
GHS06
GHS08
GHS09
Dgr
H360D
(*)(*)(*)
H300
H311
H410
  A
609-032-00-5bromofenoxim (ISO);
3,5-dibromo-4-hydroxybenzaldehyde-O-
(2,4-dinitrophenyl)-oxime
236-129-613181-17-4Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
   
609-033-00-0dinosam (ISO);
2-(1-methylbutyl)-4,6-dinitrophenol
4097-36-3Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Aquatic Acute 1
Aquatic Chronic 1
H331
H311
H301
H400
H410
GHS06
GHS09
Dgr
H331
H311
H301
H410
   
609-034-00-6salts and esters of dinosamAcute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Aquatic Acute 1
Aquatic Chronic 1
H331
H311
H301
H400
H410
GHS06
GHS09
Dgr
H331
H311
H301
H410
  A
609-035-00-1nitroethane201-188-979-24-3Flam. Liq. 3
Acute Tox. 4 (*)
Acute Tox. 4 (*)
H226
H332
H302
GHS02
GHS07
Wng
H226
H332
H302
 (*) 
609-036-00-7nitromethane200-876-675-52-5Flam. Liq. 3
Acute Tox. 4 (*)
H226
H302
GHS02
GHS07
Wng
H226
H302
 (*) 
609-037-00-25-nitroacenaphthene210-025-0602-87-9Carc. 1BH350GHS08
Dgr
H350   
609-038-00-82-nitronaphthalene209-474-5581-89-5Carc. 1B
Aquatic Chronic 2
H350
H411
GHS08
GHS09
Dgr
H350
H411
   
609-039-00-34-nitrobiphenyl202-204-792-93-3Carc. 1B
Aquatic Chronic 2
H350
H411
GHS08
GHS09
Dgr
H350
H411
   
609-040-00-9nitrofen (ISO);
2,4-dichlorophenyl 4-nitrophenyl ether
217-406-01836-75-5Carc. 1B
Repr. 1B
Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1
H350
H360D
(*)(*)(*)
H302
H400
H410
GHS08
GHS07
GHS09
Dgr
H350
H360D
(*)(*)(*)
H302
H410
   
609-041-00-42,4-dinitrophenol200-087-751-28-5Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
STOT RE 2 (*)
Aquatic Acute 1
H331
H311
H301
H373 (*)(*)
H400
GHS06
GHS08
GHS09
Dgr
H331
H311
H301
H373 (*)(*)
H400
   
609-042-00-Xpendimethalin (ISO);
N-(1-ethylpropyl)-2,6-dinitro-3,4-xylidine
254-938-240487-42-1Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
   
609-043-00-5quintozene (ISO);
pentachloronitrobenzene
201-435-082-68-8Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
   
609-044-00-0tecnazene (ISO);
1,2,4,5-tetrachloro-3-nitrobenzene
204-178-2117-18-0Acute Tox. 4 (*)
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H317
H400
H410
GHS07
GHS09
Wng
H302
H317
H410
   
609-045-00-6reaction mass of: 4,6-dinitro-2-(3-octyl)
phenyl methyl carbonate and 4,6-dinitro-2-
(4-octyl)phenyl methyl carbonate;
dinocton-6
8069-76-9Acute Tox. 4 (*)
Aquatic Acute 1
Aquatic Chronic 1
H302
H400
H410
GHS07
GHS09
Wng
H302
H410
   
609-046-00-1trifluralin (ISO)
(containing < 0,5 ppm NPDA);
α,α,α-trifluoro-2,6-dinitro-N,N-dipropyl-p-
toluidine (containing < 0,5 ppm NPDA);
2,6-dinitro-N,N-dipropyl-4-
trifluoromethylaniline
(containing < 0,5 ppm NPDA);
N,N-dipropyl-2,6-dinitro-4-
trifluoromethylaniline
(containing < 0,5 ppm NPDA)
216-428-81582-09-8Carc. 2
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H351
H317
H400
H410
GHS08
GHS07
GHS09
Wng
H351
H317
H410
 M = 10 
609-047-00-72-nitroanisole202-052-191-23-6Carc. 1B
Acute Tox. 4 (*)
H350
H302
GHS08
GHS07
Dgr
H350
H302
   
609-048-00-2sodium 3-nitrobenzenesulphonate204-857-3127-68-4Eye Irrit. 2
Skin Sens. 1
H319
H317
GHS07
Wng
H319
H317
   
609-049-00-82,6-dinitrotoluene210-106-0606-20-2Carc. 1B
Muta. 2
Repr. 2
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
STOT RE 2 (*)
Aquatic Chronic 3
H350
H341
H361f
(*)(*)(*)
H331
H311
H301
H373 (*)(*)
H412
GHS06
GHS08
Dgr
H350
H341
H361f
(*)(*)(*)
H331
H311
H301
H373 (*)(*)
H412
   
609-050-00-32,3-dinitrotoluene210-013-5602-01-7Carc. 1B
Muta. 2
Repr. 2
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
STOT RE 2 (*)
Aquatic Acute 1
Aquatic Chronic 1
H350
H341
H361f
(*)(*)(*)
H331
H311
H301
H373 (*)(*)
H400
H410
GHS06
GHS08
GHS09
Dgr
H350
H341
H361f
(*)(*)(*)
H331
H311
H301
H373 (*)(*)
H410
   
609-051-00-93,4-dinitrotoluene210-222-1610-39-9Carc. 1B
Muta. 2
Repr. 2
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
STOT RE 2 (*)
Aquatic Chronic 2
H350
H341
H361f
(*)(*)(*)
H331
H311
H301
H373 (*)(*)
H411
GHS06
GHS08
GHS09
Dgr
H350
H341
H361f
(*)(*)(*)
H331
H311
H301
H373 (*)(*)
H411
   
609-052-00-43,5-dinitrotoluene210-566-2618-85-9Carc. 1B
Muta. 2
Repr. 2
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
STOT RE 2 (*)
Aquatic Chronic 3
H350
H341
H361f
(*)(*)(*)
H331
H311
H301
H373 (*)(*)
H412
GHS06
GHS08
Dgr
H350
H341
H361f
(*)(*)(*)
H331
H311
H301
H373 (*)(*)
H412
   
609-053-00-Xhydrazine-trinitromethane414-850-9Expl. 1.1
(*)(*)(*)(*)
Self-react. A
Carc. 1B
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Skin Sens. 1
H201
H240
H350
H331
H301
H317
GHS01
GHS06
GHS08
Dgr
H201
H240
H350
H331
H301
H317
   
609-054-00-52,3-dinitrophenol; [1]
2,5-dinitrophenol; [2]
2,6-dinitrophenol; [3]
3,4-dinitrophenol; [4]
salts of dinitrophenol [5]
200-628-7 [1]
206-348-1 [2]
209-357-9 [3]
209-415-3 [4]
[5]
66-56-8 [1]
329-71-5 [2]
573-56-8 [3]
577-71-9 [4]
[5]
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
STOT RE 2 (*)
Aquatic Chronic 2
H331
H311
H301
H373 (*)(*)
H411
GHS06
GHS08
GHS09
Dgr
H331
H311
H301
H373 (*)(*)
H411
   
609-055-00-02,5-dinitrotoluene210-581-4619-15-8Carc. 1B
Muta. 2
Repr. 2
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
STOT RE 2 (*)
Aquatic Chronic 2
H350
H341
H361f
(*)(*)(*)
H331
H311
H301
H373 (*)(*)
H411
GHS06
GHS08
GHS09
Dgr
H350
H341
H361f
(*)(*)(*)
H331
H311
H301
H373 (*)(*)
H411
   
609-056-00-62,2-dibromo-2-nitroethanol412-380-969094-18-4Expl. 1.1
Carc. 2
Acute Tox. 4 (*)
STOT RE 2 (*)
Skin Corr. 1A
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H201
H351
H302
H373 (*)(*)
H314
H317
H400
H410
GHS01
GHS08
GHS05
GHS07
GHS09
Dgr
H201
H351
H302
H373 (*)(*)
H314
H317
H410
 (*)
STOT SE 3;
H335: C ≥ 1 %
T
609-057-00-13-chloro-2,4-difluoronitrobenzene411-980-83847-58-3Acute Tox. 4 (*)
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H314
H317
H400
H410
GHS05
GHS07
GHS09
Dgr
H302
H314
H317
H410
   
609-058-00-72-nitro-2-phenyl-1,3-propanediol410-360-45428-02-4STOT RE 1
Acute Tox. 4 (*)
Acute Tox. 4 (*)
Skin Sens. 1
Aquatic Chronic 2
H372 (*)(*)
H312
H302
H317
H411
GHS08
GHS07
GHS09
Dgr
H372 (*)(*)
H312
H302
H317
H411
EUH070  
609-059-00-22-chloro-6-(ethylamino)-4-nitrophenol411-440-1131657-78-8Acute Tox. 4 (*)
Skin Sens. 1
Aquatic Chronic 2
H302
H317
H411
GHS07
GHS09
Wng
H302
H317
H411
   
609-060-00-84-[(3-hydroxypropyl)amino]-3-nitrophenol406-305-992952-81-3Skin Irrit. 2
Aquatic Chronic 2
H315
H411
GHS07
GHS09
Wng
H315
H411
   
609-061-00-3(E,Z)-4-chlorophenyl(cyclopropyl)ketone O-
(4-nitrophenylmethyl)oxime
406-100-494097-88-8Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H317
H400
H410
GHS07
GHS09
Wng
H317
H410
   
609-062-00-92-bromo-2-nitropropanol407-030-724403-04-1Acute Tox. 3 (*)
Acute Tox. 4 (*)
STOT RE 2 (*)
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H311
H302
H373 (*)(*)
H314
H317
H400
H410
GHS06
GHS08
GHS05
GHS09
Dgr
H311
H302
H373 (*)(*)
H314
H317
H410
   
609-063-00-42-[(4-chloro-2-nitro-
phenyl)amino]ethanol
413-280-859320-13-7Acute Tox. 4 (*)
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411
   
609-064-00-Xmesotrione(ISO);
2-[4-(methylsulfonyl)-2-
nitrobenzoyl]-1,3-
cyclohexanedione
104206-82-8Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410   
609-065-00-52-nitrotoluene201-853-388-72-2Carc. 1B
Muta. 1B
Repr. 2
Acute Tox. 4 (*)
Aquatic Chronic 2
H350
H340
H361f
(*)(*)(*)
H302
H411
GHS08
GHS07
GHS09
Dgr
H350
H340
H361f
(*)(*)(*)
H302
H411
   
Folgender Eintrag wird ab 01.03.2018 gestrichen:
609-066-00-0
lithium sodium
3-amino-10-{4-(10-amino-
6,13-dichloro-4,11-
disulfonatobenzo[5,6]
[1,4]oxazino[2,3-
b]phenoxazine-3-yla-
mino)-6-[methyl(2-
sulfonato-ethyl)amino]-
1,3,5-triazin-2-
ylamino}-6,13-dichloro-
benzo[5,6][1,4]oxa-
zino[2,3-b]phenoxazine-
4,11-disulfonate
418-870-9154212-58-5Acute Tox. 4 (*)
Acute Tox. 4 (*)
Acute Tox. 4 (*)
STOT SE 2 (*) (*)
H332
H312
H302
H371(*)(*)
GHS08
GHS07
Dgr
H332
H312
H302
H371 (*)(*)
   
609-067-00-6sodium and potassium 4-(3-aminopropyla-
mino)-2,6-bis[3-(4-methoxy-2-sulfopheny-
lazo)-4-hydroxy-2-sulfo-7-naphthylamino]-
1,3,5-triazine
416-280-6156769-97-0Skin Sens. 1H317GHS07
Wng
H317   
609-068-00-1musk xylene;
5-tert-butyl-2,4,6-trinitro-m-xylene
201-329-481-15-2Expl. 1.1
Carc. 2
Aquatic Acute 1
Aquatic Chronic 1
H201
H351
H400
H410
GHS01
GHS08
GHS09
Wng
H201
H351
H410
  T
609-069-00-7musk ketone;
3,5-dinitro-2,6-dimethyl-4-tert-
butylacetophenone;
4´-tert-butyl-2´,6´-dimethyl-3´,5´-
dinitroacetophenone
201-328-981-14-1Carc. 2
Aquatic Acute 1
Aquatic Chronic 1
H351
H400
H410
GHS08
GHS09
Wng
H351
H410
   
609-070-00-21,4-dichloro-2-(1,1,2,3,3,3-hexafluoropro-
poxy)-5-nitrobenzene
415-580-4130841-23-5Acute Tox. 4 (*)
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H317
H400
H410
GHS07
GHS09
Wng
H302
H317
H410
   
609-071-00-8reaction mass of: 2-methylsulfanyl-4,6-bis-
(2-hydroxy-4-methoxy-phenyl)-1,3,5-triazine;
2-(4,6-bis-methylsulfanyl-1,3,5-triazin-2-yl)-
5-methoxy-phenol
423-520-3156137-33-6Skin Sens. 1H317GHS07
Wng
H317   
609-072-00-34-mesyl-2-nitrotoluene430-550-01671-49-4Repr. 2
Acute Tox. 4 *
Skin Sens. 1
Aquatic Chronic 3
H361f ***
H302
H317
H412
GHS08
GHS07
Wng
H361f ***
H302
H317
H412
   
609-073-00-9lithium potassium sodium
N,N´´-bis{6-[7-[4-(4-chloro-1,3,5-
triazin-2-yl)amino-4-
(2-ureidophenylazo)]naphthalene-
1,3,6-trisulfonato]}-N´-(2-aminoethyl)
piperazine
427-850-9Skin Sens. 1H317GHS07
Wng
H317   
610-001-00-3trichloronitromethane;
chloropicrin
200-930-976-06-2Acute Tox. 2 (*)
Acute Tox. 4 (*)
Eye Irrit. 2
STOT SE 3
Skin Irrit. 2
H330
H302
H319
H335
H315
GHS06
Dgr
H330
H302
H319
H335
H315
   
610-002-00-91,1-dichloro-1-nitroethane209-854-0594-72-9Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
H331
H311
H301
GHS06
Dgr
H331
H311
H301
   
610-003-00-4chlorodinitrobenzeneAcute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
STOT RE 2 (*)
Aquatic Acute 1
Aquatic Chronic 1
H331
H311
H301
H373 (*)(*)
H400
H410
GHS06
GHS08
GHS09
Dgr
H331
H311
H301
H373 (*)(*)
H410
  C
610-004-00-X2-chloro-1,3,5-trinitrobenzene201-864-388-88-0Expl. 1.1
Acute Tox. 2 (*)
Acute Tox. 1
Acute Tox. 2 (*)
Aquatic Acute 1
Aquatic Chronic 1
H201
H330
H310
H300
H400
H410
GHS01
GHS06
GHS09
Dgr
H201
H330
H310
H300
H410
   
610-005-00-51-chloro-4-nitrobenzene202-809-6100-00-5Carc. 2
Muta. 2
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 3 (*)
STOT RE 2 (*)
Aquatic Chronic 2
H351
H341
H331
H311
H301
H373 (*)(*)
H411
GHS06
GHS08
GHS09
Dgr
H351
H341
H331
H311
H301
H373 (*)(*)
H411
   
610-006-00-0chloronitroanilines with the exception of
those specified elsewhere in this Annex
Acute Tox. 2 (*)
Acute Tox. 1
Acute Tox. 2 (*)
STOT RE 2 (*)
Aquatic Chronic 2
H330
H310
H300
H373 (*)(*)
H411
GHS06
GHS08
GHS09
Dgr
H330
H310
H300
H373 (*)(*)
H411
  AC
610-007-00-61-chloro-1-nitropropane209-990-0600-25-9Acute Tox. 4 (*)
Acute Tox. 4 (*)
H332
H302
GHS07
Wng
H332
H302
 (*) 
610-008-00-12,6-dichloro-4-nitroanisole403-350-617742-69-7Acute Tox. 3 (*)
Aquatic Chronic 2
H301
H411
GHS06
GHS09
Dgr
H301
H411
   
610-009-00-72-chloro-4-nitroaniline204-502-2121-87-9Acute Tox. 4 (*)
Aquatic Chronic 2
H302
H411
GHS07
GHS09
Wng
H302
H411
   
610-010-00-22-bromo-1-(2-furyl)-2-nitroethylene406-110-935950-52-8Acute Tox. 4 (*)
STOT RE 2 (*)
Skin Corr. 1B
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H302
H373 (*)(*)
H314
H317
H400
H410
GHS08
GHS05
GHS07
GHS09
Dgr
H302
H373 (*)(*)
H314
H317
H410
   
611-001-00-6azobenzene203-102-5103-33-3Carc. 1B
Muta. 2
Acute Tox. 4 (*)
Acute Tox. 4 (*)
STOT RE 2 (*)
Aquatic Acute 1
Aquatic Chronic 1
H350
H341
H332
H302
H373 (*)(*)
H400
H410
GHS08
GHS07
GHS09
Dgr
H350
H341
H332
H302
H373 (*)(*)
H410
   
611-002-00-1azoxybenzene207-802-1495-48-7Acute Tox. 4 (*)
Acute Tox. 4 (*)
H332
H302
GHS07
Wng
H332
H302
   
611-003-00-7fenaminosulf (ISO);
sodium 4-dimethylaminoben-
zenediazosulphonate
205-419-4140-56-7Acute Tox. 3 (*)
Acute Tox. 4 (*)
Aquatic Chronic 3
H301
H312
H412
GHS06
Dgr
H301
H312
H412
   
611-004-00-2methyl-ONN-azoxymethyl acetate;
methyl azoxy methyl acetate
209-765-7592-62-1Carc. 1B
Repr. 1B
H350
H360D
(*)(*)(*)
GHS08
Dgr
H350
H360D
(*)(*)(*)
   
611-005-00-8disodium
{5-[(4'-((2,6-hydroxy-3-((2-hyd-
roxy-5-sulphophenyl)azo)phe-
nyl)azo)(1,1'-biphenyl)-
4-yl)azo]salicylato(4-)}cupra-
te(2-);
CI Direct Brown 95
240-221-116071-86-6Carc. 1BH350GHS08
Dgr
H350   
611-006-00-34-o-tolylazo-o-toluidine;
4-amino-2',3-dimethylazo-
benzene;
fast garnet GBC base;
AAT;
o-aminoazotoluene
202-591-297-56-3Carc. 1B
Skin Sens. 1
H350
H317
GHS08
Dgr
H350
H317
   
611-007-00-9tricyclazole (ISO);
5-methyl-1,2,4-triazolo(3,4-b)benzo-1,3-thiazole;
255-559-541814-78-2Acute Tox. 4 (*)H302GHS07
Wng
H302   
611-008-00-44-aminoazobenzene;
4-phenylazoaniline
200-453-660-09-3Carc. 1B
Aquatic Acute 1
Aquatic Chronic 1
H350
H400
H410
GHS08
GHS09
Dgr
H350
H410
   
611-009-00-Xsodium (1-(5-(4-(4-anilino-3-sulpho-
phenylazo)-2-methyl-5-methyl-
sulphonamidophe-
nylazo)-4-hydroxy-2-oxido-3-(phenylazo)
phenylazo)-5-nitro-4-sulphonato-2-naphtholato)iron(II)
401-220-3Acute Tox. 4 (*)
Aquatic Chronic 3
H332
H412
GHS07
Wng
H332
H412
   
611-010-00-52'-(2-cyano-4,6-dinitrophenyl-
azo)-5'-(N,N-dipropylamino)pro-
pionanilide
403-010-7106359-94-8Skin Sens. 1
Aquatic Chronic 3
H317
H412
GHS07
Wng
H317
H412
   
611-011-00-0N,N,N',N'-tetramethyl-3,3'-(pro-
pylenebis
(iminocarbonyl-4,1-phenylen-
azo(1,6-dihydro-2-hydroxy-4-
methyl-6-oxopyridine-
3,1-diyl)))di(propylam-
monium) dilactate
403-340-1Eye Dam. 1
Aquatic Chronic 2
H318
H411
GHS05
GHS09
Dg
H318
H411
   
611-012-00-6reaction mass of
2,2-iminodiethanol
6-methyl-2-(4-(2,4,6-triamino-
pyrimidin-5-ylazo)phenyl)ben-
zothiazole-7-sulfonate and
2-methylaminoethanol 6-methyl-2-(4-(2,4,6-triamino-
pyrimidin-5-ylazo)phenyl)
benzothiazole-7-sulfonate and N,N-diethylpropane-1,3-di-
amine 6-methyl-2-(4-(2,4,6-
triaminopyrimidin-5-ylazo)phe-
nyl)benzothiazole-7-sulfonate
403-410-1114565-65-0Skin Sens. 1H317GHS07
Wng
H317   
611-013-00-1trilithium-1-hydroxy-7-(3-
sulfonatoanilino)-2-(3-methyl-4-
(2-methoxy-4-(3-sulfonato-
phenylazo)phenylazo)phenyl-
azo)naphthalene-3-sulfonate
403-650-7117409-78-6Expl. 1.3
(*)(*)(*)(*)
Aquatic Chronic 2
H203
H411
GHS01
GHS09
Dgr
H203
H411
   
611-014-00-7(tetrasodium 1-(4-(3-acet-
amido-4-(4'-nitro-2,2'-disulfo-
natostilben-4-ylazo)anilino)-6-
(2,5-disulfonatoanilino)-1,3,5-
triazin-2-yl)-3-carboxypyridi-
nium) hydroxide
404-250-5115099-55-3Skin Sens. 1H317GHS07
Wng
H317   
611-015-00-2tetrasodium 4-amino-5-hydroxy-
6-(4-(2-(2-(sulfonatooxy)ethyl-
sulfonyl)ethylcarbamoyl)
phenylazo)-3-(4-(2-(sulfonato-
oxy)ethylsulfonyl)phenyl-
azo)naphthalene-2,7-disulfonate
404-320-5116889-78-2Skin Sens. 1H317GHS07
Wng
H317   
611-016-00-8reaction mass of
1,1'-((dihydroxyphenylene)
bis(azo-3,1-phenylenazo(1-(3-dimethylaminopropyl)-1,2-di-
hydro-6-hydroxy-4-methyl-
2-oxopyridine-5,3-diyl)))dipyridinium dichloride dihydrochloride, mixed isomers and 1-(1-(3-dimethylaminopropyl)-
5-(3-((4-(1-(3-dimethylamino-
propyl)-1,6-dihydro-2-
hydroxy-4-methyl-6-oxo-5-
pyridinio-3-pyridylazo)phenyl-
azo)-2,4(or2,6 or3,5)-dihyd-
roxyphenylazo)phenylazo)-1,2-
dihydro-6-hydroxy-4-methyl-2-
oxo-3-pyridyl)pyridinium dichloride
404-540-1Skin Sens. 1H317GHS07
Wng
H317   
611-017-00-32-(4-(diethylaminopropyl-
carbamoyl)phenylazo)-3-oxo-
N-(2,3-dihydro-2-oxobenzimi-
dazol-5-yl)butyramide
404-910-2Skin Sens. 1
Aquatic Chronic 2
H317
H411
GHS07
GHS09
Wng
H317
H411
   
611-018-00-9tetraammonium
5-(4-(7-amino-1-hydroxy-
3-sulfonato-2-naphthylazo)-6-
sulfonato-1-naphthylazo)iso-
phthalate
405-130-5Skin Sens. 1H317GHS07
Wng
H317   
611-019-00-4tetralithium
6-amino-4-hydroxy-3-(7-sulfo-
nato-4-(4-sulfonatophenylazo)-
1-naphthylazo)naphthalene-
2,7-disulfonate
405-150-4106028-58-4Skin Sens. 1H317GHS07
Wng
H317   
611-020-00-Xtetrakis(tetramethylammonium)
6-amino-4-hydroxy-3-(7-
sulfonato-4-(4-sulfonatophe-
nylazo)-1-naphthylazo)naph-
thalene-2,7-disulfonate
405-170-3116340-05-7Acute Tox. 3 (*)
Skin Sens. 1
Aquatic Chronic 3
H301
H317
H412
GHS06
Dgr
H301
H317
H412
   
611-021-00-52-(4-(4-cyano-3-methyliso-
thiazol-5-ylazo)-N-ethyl-3-
methylanilino)ethyl acetate
405-480-9Acute Tox. 4 (*)
STOT RE 2 (*)
Skin Irrit. 2
Aquatic Chronic 4
H302
H373 (*)(*)
H315
H413
GHS08
GHS07
Wng
H302
H373 (*)(*)
H315
H413
   
611-022-00-04-dimethylaminobenzene-
diazonium 3-car-boxy-4-hydroxy-
benzenesulfonate
404-980-4Self-react. C
Acute Tox. 3 (*)
Acute Tox. 3 (*)
Acute Tox. 4 (*)
STOT RE 2 (*)
Eye Dam. 1
Skin Sens. 1
Aquatic Acute 1
Aquatic Chronic 1
H242
H331
H301
H312
H373 (*)(*)
H318
H317
H400
H410
GHS02
GHS06
GHS08
GHS05
GHS09
Dgr
H242
H331
H301
H312
H373 (*)(*)
H318
H317
H410
  T
611-023-00-6disodium 7-(4,6-dichloro-1,3,5-triazin-2-
ylamino)-4-hydroxy-3-(4-(2-
(sulfonatooxy)ethylsulfo-
nyl)phenylazo) naphthalene-2-sulfonate
404-600-7Skin Sens. 1H317GHS07
Wng
H317   
611-024-00-1Benzidine based azo dyes;
4,4'-diarylazobiphenyl dyes, with the
exception of those specified elsewhere in
this Annex
Carc. 1BH350GHS08
Dgr
H350  A
611-025-00-7disodium 4-amino-3-[[4'-[(2,4-diaminophe-
nyl)azo][1,1'-biphenyl]-4-yl]azo]-5-hydroxy-
6-(phenylazo)naphtalene-2,7-disulphonate;
C.I. Direct Black 38
217-710-31937-37-7Carc. 1B
Repr. 2
H350
H361d
(*)(*)(*)
GHS08
Dgr
H350
H361d
(*)(*)(*)
   
611-026-00-2tetrasodium 3,3'-[[1,1'-biphenyl]-
4,4'-diylbis(azo)]bis[5-amino-
4-hydroxynaphthalene-2,7-
disulphonate];
C.I. Direct Blue 6
220-012-12602-46-2Carc. 1B
Repr. 2
H350
H361d
(*)(*)(*)
GHS08
Dgr
H350
H361d
(*)(*)(*)
   
611-027-00-8disodium 3,3'-[[1,1'-biphenyl]-
4,4'-diylbis(azo)]bis(4-amino-
naphthalene-1-sulphonate);
C.I. Direct Red 28
209-358-4573-58-0Carc. 1B
Repr. 2
H350
H361d
(*)(*)(*)
GHS08
Dgr
H350
H361d
(*)(*)(*)
   
611-028-00-3C,C´-azodi(formamide)204-650-8123-77-3Resp. Sens. 1H334GHS08
Dgr
H334  G
611-029-00-9o-dianisidine based azo dyes;
4,4'-diarylazo-3,3'-dimethoxy-
biphenyl dyes with the exception of those mentioned elsewhere in this Annex
Carc. 1BH350GHS08
Dgr
H350  A
611-030-00-4o-tolidine based dyes;
4,4'-diarylazo-3,3'-dimethylbi-
phenyl dyes, with the exception of those mentioned elsewhere in this Annex
Carc. 1BH350GHS08
Dgr
H350  A
611-031-00-X4,4'-(4-iminocyclohexa-2,5-
dienylidenemethylene)di-
aniline hydrochloride;
C.I. Basic Red 9
209-321-2569-61-9Carc. 1BH350GHS08
Dgr
H350   
611-032-00-51,4,5,8-tetraaminoanthra-
quinone;
C.I. Disperse Blue 1
219-603-72475-45-8Carc. 1B
Skin Irrit. 2
Eye Dam. 1
Skin Sens. 1
H350
H315
H318
H317
GHS08
GHS05
GHS07
Dgr
H350
H315
H318
H317
   
611-033-00-0hexasodium
[4,4''-azoxybis(2,2'-disulfona-
tostilbene-4,4'-diylazo)]-bis[5'-
sulfonatobenzene-2,2'-
diolato-O(2),O(2),N(1)]-copper(II)
400-020-382027-60-9Aquatic Chronic 2H411GHS09H411   
611-034-00-6N-(5-(bis(2-methoxyethyl)ami-
no)-2-((5-nitro-2,1-benziso-
thiazol-3-yl)azo)phenylacet-
amide
402-430-8105076-77-5Aquatic Chronic 4H413H413   
611-035-00-1tetralithium
6-amino-4-hydroxy-3-[7-
sulfonato-4-(5-sulfonato-2-
naphthylazo)-1-naphthyl-
azo]naphthalene-2,7-disulfonate
403-660-1107246-80-0Aquatic Chronic 2H411GHS09H411   
611-036-00-72-(4-(5,6(or 6,7)-dichloro-1,3-
benzothiazol-2-ylazo)-N-
methyl-m-toluidino)ethyl acetate
405-440-0Skin Sens. 1H317GHS07
Wng
H317   
611-037-00-23(or 5)-(4-(N-benzyl-N-
ethylamino)-2-methylphenyl-
azo)-1,4-dimethyl-1,2,4-tria-
zolium methylsulphate
406-055-0124584-00-5Acute Tox. 4 (*)
Eye Dam. 1
Skin Sens. 1
Aquatic Chronic 2
H302
H318
H317
H411
GHS05
GHS07
GHS09
Dgr
H302
H318
H317
H411
   
611-038-00-8trisodium 1-hydroxynaphtha-
lene-2-azo-4'(5',5''-dimethyl-
biphenyl)-4''-azo(4''-phenyl-
sulfonyloxybenzene)- 2',2'',4-trisulfonate
406-820-9Eye Irrit. 2H319GHS07
Wng
H319   
611-039-00-37-[((4,6-dichloro-1,3,5-triazin-2-
yl)amino)-4-hydroxy-3-(4-((2-
sulfoxy)ethyl)sulfonyl)phenyl-
azo]naphthalene-2-sulfonic acid
407-050-6117715-57-8Skin Sens. 1H317GHS07
Wng
H317   
611-040-00-93-(5-acetylamino-4-(4-[4,6-
bis(3-diethylaminopropyl-
amino)-1,3,5-triazin-2-yl-
amino]phenylazo)-2-(2-
methoxyethoxy)phenylazo)-6-
amino-4-hydroxy-2-naphthalenesulfonic acid
407-670-7115099-58-6Aquatic Acute 1
Aquatic Chronic 1
H400
H410
GHS09
Wng
H410